Eli Lilly and Company
LLY · NYSE · USD · Healthcare
1What is happening
Eli Lilly and Company has fallen 7% since its 6-week high on 05/11/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-6.8%
Other view · 29 analystsHorizon: 12 months26 Buy · 3 Hold · 2 Sell2Our assessment
No dip40How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-6.8%
Highest daily price: $1,453.00 on 05/11/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-6.8%
Highest price in 52 weeks: $1,453.00 (Yahoo)
What analysts expect
Most of the 29 analysts say buy. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 2684 %
- Hold
- 310 %
- Sell
- 26 %
Average price target$1,453.40
$940.00 to $1,690.00 · today $1,354.00
$940.00Ø $1,453.40$1,690.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
Dates
- 13NovEx-dividendBuying from this day no longer gets the next dividend. The price usually drops by about the dividend.
- 10DecDividend paymentThe dividend is paid on this day.
The company in figures
- Market value
- 1.2 tn $
- All shares together at the current price.
- P/E
- 44
- Price divided by earnings per share, last 12 months.
- Dividend yield
- 0.51 %
- Yearly dividend relative to the price.
- 52-week range
- $850.51 – $1,453.00
- Lowest and highest price of the last year.
Catalysts
36 h ago- News, last 10 days
- no recent news
- Next earnings
- —
- Last report
- 29/10/2026 +17.9% vs estimate
Key figures
- Market value
- 1.2 tn $Large cap
- P/E
- 44.0
- Dividend yield
- 0.51 %
- Volume today
- 1.4 × Øabout usual
- Beta
- 0.39swings less than the market
- 52-week range
- $850.51 – $1,453.00price at 84 % of the range
About Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd; Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease, as well as Strategic partnership with NVIDIA Corporation. The company also has a research collaboration agreement with Insilico Medicine for the development of advance therapies. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
- Headquarters:
- Indianapolis, United States
- 52-week range:
- $850.51 – $1,453.00
- Website:
- lilly.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.